Evidence map›Paper›PMID 28584922›Full record

ArticlePlant cell reports2017

Deletion of a target gene in Indica rice via CRISPR/Cas9.

Ying Wang, Lizhao Geng, Menglong Yuan, Juan Wei, Chen Jin, Min Li, Kun Yu, Ya Zhang, Huaibing Jin, Eric Wang and 3 more

Abstract read
PubMed Publisher
In one paragraph

Article in Plant cell reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Breeding rice for yield improvement through CRISPR/Cas9 genome editing method: current technologies and examples.Physiology and molecular biology of plants : an international journal of functional plant biology · 2024
    Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Ying WangSyngenta Biotechnology China, No. 25, Life Science Park Road, Zhongguancun Life Science Park, Beijing, 102206, China.
Lizhao GengSyngenta Biotechnology China, No. 25, Life Science Park Road, Zhongguancun Life Science Park, Beijing, 102206, China.
Menglong YuanSyngenta Biotechnology China, No. 25, Life Science Park Road, Zhongguancun Life Science Park, Beijing, 102206, China.
Juan WeiSyngenta Biotechnology China, No. 25, Life Science Park Road, Zhongguancun Life Science Park, Beijing, 102206, China.
Chen JinSyngenta Biotechnology China, No. 25, Life Science Park Road, Zhongguancun Life Science Park, Beijing, 102206, China.
Min LiSyngenta Biotechnology China, No. 25, Life Science Park Road, Zhongguancun Life Science Park, Beijing, 102206, China.
Kun YuSyngenta Biotechnology China, No. 25, Life Science Park Road, Zhongguancun Life Science Park, Beijing, 102206, China.
Ya ZhangSyngenta Biotechnology China, No. 25, Life Science Park Road, Zhongguancun Life Science Park, Beijing, 102206, China.
Huaibing JinSyngenta Biotechnology China, No. 25, Life Science Park Road, Zhongguancun Life Science Park, Beijing, 102206, China.
Eric WangSyngenta Biotechnology China, No. 25, Life Science Park Road, Zhongguancun Life Science Park, Beijing, 102206, China.
Zhijian ChaiSyngenta Biotechnology China, No. 25, Life Science Park Road, Zhongguancun Life Science Park, Beijing, 102206, China.
Xiangdong FuInstitute of Genetics and Developmental Biology, Chinese Academy of Sciences, Beijing, China.
Xianggan LiSyngenta Biotechnology China, No. 25, Life Science Park Road, Zhongguancun Life Science Park, Beijing, 102206, China. Xianggan.li@syngenta.com.ORCID http://orcid.org/0000-0002-6269-7021

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

key messageUsing CRISPR/Cas9, we successfully deleted large fragments of the yield-related gene DENSE AND ERECT PANICLE1 in Indica rice at relatively high frequency and generated gain-of-function dep1 mutants. CRISPR (clustered regularly interspaced short palindromic repeats)/Cas9 is a rapidly developing technology used to produce gene-specific modifications in both mammalian and plant systems. Most CRISPR-induced modifications in plants reported to date have been small insertions or deletions. Few large target gene deletions have thus far been reported, especially for Indica rice. In this study, we designed multiple CRISPR sgRNAs and successfully deleted DNA fragments in the gene DENSE AND ERECT PANICLE1 (DEP1) in the elite Indica rice line IR58025B. We achieved deletion frequencies of up to 21% for a 430 bp target and 9% for a 10 kb target among T0 events. Constructs with four sgRNAs did not generate higher full-length deletion frequencies than constructs with two sgRNAs. The multiple mutagenesis frequency reached 93% for four targets, and the homozygous mutation frequency reached 21% at the T0 stage. Important yield-related trait characteristics, such as dense and erect panicles and reduced plant height, were observed in dep1 homozygous T0 mutant plants produced by CRISPR/Cas9. Therefore, we successfully obtained deletions in DEP1 in the Indica background using the CRISPR/Cas9 editing tool at relatively high frequency.

Indexed as

CRISPR-Cas SystemsOryzaPlant ProteinsPlants, Genetically ModifiedPlant ProteinsCRISPR/Cas9DEP1Indica ricesgRNATarget gene deletion

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.